ZYNEX INC — Director's Dealing 2018

Jul 9, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ZYNEX INC (ZYXI)
CIK: 0000846475
Period of Report: 2018-07-09

Reporting Person: Sandgaard Thomas (President, CEO and Chairman, 10% Owner)
Reporting Person: Sandgaard Holdings LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2129571	Direct
Common Stock	15200000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock	$0.22	2023-10-31	A (190000)		Direct
Option to Purchase Common Stock	$0.14	2026-01-02	A (203571)		Direct
Option to Purchase Common Stock	$2.76	2027-12-14	A (1000)		Direct

Footnotes

F1: Represents options to purchase 190,000 shares of the Issuer's common stock issued pursuant to the Zynex Medical Holdings Inc. 2005 Stock Option Plan (the "2005 Plan") which have vested in full.

F2: Represents options to purchase 203,571 shares of common stock issued pursuant to the 2005 Plan which have vested in full.

F3: Represents options to purchase 1,000 shares of common stock issued on December 14, 2017 pursuant to the Issuer's 2017 Stock Incentive Plan of which no options are vested and which total options vest in four equal annual installments beginning on the one year anniversary of the issue date.